Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
Clinical trial NCT04260698 · COMPLETED
Trial details
- NCT number
- NCT04260698
- Sponsor
- Gamida Cell ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-08
- Primary completion
- 2025-05-08
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.